Scientists have gained greater clarity in the brain regions and neurons that control metabolism, body temperature and energy use. A team of researchers discovered which chemicals influence the signals ...

Scientists at Pennington Biomedical Research Center have gained greater clarity in the brain regions and neurons that control ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...

While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

We believe these neurons manage the body's ability to adapt to a variety ... by integrating signals like leptin and the gut hormone glucagon-like-peptide-1 or GLP-1." In addition to identifying ...